8th May 2013 14:00
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 7 May 2013, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below. The change in interest relates to the vesting of awards made in May 2010 under the AstraZeneca Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals listed have now become beneficially entitled to 47% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting. The interest of Lynn Tetrault is in the Company's American Depositary Shares (ADSs). One ADS equals one ordinary share.
Name | Shares awarded | Shares vested | Shares withheld | Net shares received | Market price on vesting |
Mene Pangalos |
26,214 |
12,320 |
5,791 |
6,529 |
3339.5p |
Jeff Pott |
24,903 |
11,704 |
5,575 |
6,129 |
3339.5p |
David Smith |
24,903 |
11,704 |
5,235 |
6,469 |
3339.5p |
Lynn Tetrault |
48,585 |
22,834 |
10,550 |
12,284 |
$51.62 |
A C N Kemp
Company Secretary
8 May 2013
Related Shares:
Astrazeneca